Autolus Therapeutics Plc (AUTL)
1.38
-0.06
(-4.17%)
USD |
NASDAQ |
Jan 16, 16:00
1.34
-0.04
(-2.90%)
After-Hours: 06:48
Autolus Therapeutics EPS Diluted (Quarterly): -0.2955 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Mereo BioPharma Group Plc | -0.0436 |
| Bicycle Therapeutics Plc | -0.8476 |
| DBV Technologies SA | -1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -78.64M |
| Revenue (Quarterly) | 21.07M |
| Total Expenses (Quarterly) | 99.71M |
| Enterprise Value | 323.55M |
| Gross Profit Margin (Quarterly) | -51.21% |
| Profit Margin (Quarterly) | -373.3% |
| Earnings Yield | -61.17% |
| Normalized Earnings Yield | -61.17 |